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Methods
We used a published simulated dataset that is available online
(http://labs.fhcrc.org/pepe/dabs/datasets.html). The data comprise a cohort of 10,000 subjects
followed for 10 years for cardiovascular events. Each subject has a covariate called the baseline
risk score, and 5 markers labeled Y, M1, M2, M3, M4. By design, Y is predictive while M1-M4 are
not. We used likelihood-ratio statistics to evaluate the significance of adding Y or M1-M4 to the
baseline score.
For model development, we selected subjects randomly with probability .04 (n=419 were
selected). Using this training dataset, we fit three logistic regression models (Table 1), a
baseline model and two expanded models.
The development and assessment of risk models in the same dataset leads to optimistic
estimates of prediction performance. An independent validation dataset is generally considered
ideal for obtaining an unbiased assessment of the performance of risk models derived from a
model development dataset. We used the remaining 9581 subjects as an independent
validation dataset. We calculated three statistics to compare the prediction performance of the
baseline model with the expanded models: the ΔAUC statistic, the category-free NRI2 and a
two-category NRI1 with threshold at 1% risk. Standard p-values were calculated.1,2
We also repeated the exercise 100 times, each time randomly selecting 419 subjects for model
fitting and assessing performance with the remaining 9581 validation set subjects.
Results
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In the entire cohort, likelihood-ratio statistics confirm that Y is predictive (p<0.001). M1-M4 are
not significant (p=0.503).
Table 2 shows the ΔAUC and NRI statistics calculated in the validation dataset. All measures
correctly indicate that Y improves prediction. Because M1-M4 are not associated with outcome,
these markers simply add random noise to the baseline model: as a result the risk model with
M1-M4 is actually less predictive than the baseline model. The ΔAUC measure, having a
negative sign, corroborates this fact (p < 0.001). However, both NRI statistics are positive
(p<.001) and provide statistically significant support for the incorrect conclusion that prediction
is improved by M1-M4 .
Of the 100 repetitions of this exercise, the category-free NRI and two-category NRI statistics
were significantly positive in 62% and 82% of validation datasets, respectively. In contrast, the
ΔAUC was statistically significantly positive in 0%.

Discussion
In the illustrative dataset, the ΔAUC correctly indicated that including M1-M4 in the model
reduces prediction performance while the NRI statistics erroneously indicated that M1-M4 add
predictive information. This phenomenon was not an anomaly of one specific choice for
training and test datasets. Moreover, extensive simulation studies and mathematical
arguments presented recently show that this is a general phenomenon.4,5 The problem is
more severe when training sets are small and several candidate predictors are studied.
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The ΔAUC statistic is considered an “insensitive” measure, possibly due to its narrow scale or
use of invalid conservative p-values in training datasets.6 However, the NRI suffers a more
serious problem: being “too sensitive” even to non-existent improvements in prediction. We
recommend avoiding use of the NRI in practice.

References

1. Pencina MJ, D’Agostino Sr RB, D’Agostino Jr , Vasan RS. Evaluating the added predictive
ability of a new marker: From area under the ROC curve to reclassification and beyond.
Stat Med. 2008;27(2):157-172.
2. Pencina MJ, D’Agostino Sr RB, Steyerberg EW. Extensions of net reclassification
improvement calculations to measure usefulness of new biomarkers. Stat Med.
2011;30(1):11-21.
3. Hlatky MA, Greenland P, Arnett DK, et al. Criteria for evaluation of novel markers of
cardiovascular risk: A scientific statement from the American Heart Association.
Circulation. 2009;119(17):2408-2416.
4. Hilden J, Gerds T. A note on the evaluation of novel biomarkers: do not rely on
integrated discrimination improvement and net reclassification index [published online
ahead of print April 2, 2013]. Stat Med. doi: 10.1002/sim.5804.
5. Pepe MS, Fan J, Feng Z, Gerds T, Hilden J. The Net Reclassification Index (NRI): a
misleading measure of prediction improvement with mis-calibrated or over fit models.

Hosted by The Berkeley Electronic Press

UW Biostatistics Working Paper Series. Working Paper 392
http://biostats.bepress.com/uwbiostat/paper392
6. Pepe, MS, Kerr, KF, Longton, G and Wang, Z. Testing for improvement in prediction
model performance [published online ahead of print April 30, 2013]. Stat Med. doi:
10.1002/sim.5727

http://biostats.bepress.com/uwbiostat/paper394

Table 1. Log odds ratios (OR) for models fit using the model development training dataset (n=419). The
expanded models included the baseline score and either Y or the four marker panel: M1-M4 .
Predictors
baseline score
Y
M1
M2
M3
M4
intercept

Baseline

Y added

2.03
—
—
—
—
—

1.99
0.81
—
—
—
—

–4.39

–4.66

M1-M4 added
Log(OR)
2.09
—
–0.21
–0.57
–0.30
0.20
–4.64
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Table 2. Independent validation data (n=9581) estimates of measures of improved prediction for models
fit with a training data set (Table 1).
Markers Added to the Baseline Risk Score
Performance Measure

M1

M2--M5

Δ AUC
P-value

0.034
<.001

-.012
<.001

Category-free NRI
P-value

0.690
<.001

0.129
<.001

Two-category NRI
P-value

0.065
<.001

0.023
<.001
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